FDA Form 483s for SI Group, John M. Kirkwood, MD, Emily A. DiMango, MD, and Others – Drug Inspections

Original Request: Please provide the following inspection-related document(s) in electronic PDF format related to Product Type: Drugs: The 483(s) (in electronic format) for the inspection of SI Group, Inc. (FEI 3011012288), located in Orangeburg, South Carolina, United States, inspection ending 2025-01-17, with project area(s): Drug Quality Assurance. The 483(s) (in electronic format) for the inspection of John M. Kirkwood, MD (FEI 1283402), located in Pittsburgh, Pennsylvania, United States, inspection ending 2024-10-21, with project area(s): Bioresearch Monitoring. The 483(s) (in electronic format) for the inspection of Emily A. DiMango, M.D. (FEI 3013753808), located in New York, New York, United States, inspection ending 2024-08-13, with project area(s): Bioresearch Monitoring. The 483(s) (in electronic format) for the inspection of Marc A. Bjurlin, D.O. (FEI 3030732629), located in Chapel Hill, North Carolina, United States, etc
Tags: Pharma, 483, 2025